TP

Thomas Charles PERTEL

AT Allogene Therapeutics: 5 patents #4 of 37Top 15%
Pfizer: 3 patents #1,612 of 5,153Top 35%
CE Cellectis: 1 patents #38 of 71Top 55%
📍 San Mateo, CA: #802 of 3,727 inventorsTop 25%
🗺 California: #73,997 of 386,348 inventorsTop 20%
Overall (All Time): #609,535 of 4,157,543Top 15%
8
Patents All Time

Issued Patents All Time

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
12163153 Methods of manufacturing allogeneic CAR T cells Diego A. VARGAS-INCHAUSTEGUI, Barbra Johnson SASU 2024-12-10
11912776 Chimeric antigen receptors targeting B-cell maturation antigen Tracy Chia-Chien KUO, Bijan Andre Boldajipour, Javier Fernando Chaparro Riggers, Philippe Duchateau, Roman Galetto +6 more 2024-02-27
11896617 Polynucleotides encoding rituximab-resistant chimeric antigen receptors Barbra Johnson SASU, Mark Leonard 2024-02-13
11781248 Anti-TALEN antibodies and uses thereof Barbra Johnson SASU 2023-10-10
11732041 Antibodies against 4G7-derived chimeric antigen receptors Barbra Johnson SASU, Tao Sai 2023-08-22
11312782 Chimeric antigen receptors targeting B-cell maturation antigen Tracy Chia-Chien KUO, Bijan Andre Boldajipour, Javier Fernando Chaparro Riggers, Philippe Duchateau, Roman Galetto +6 more 2022-04-26
11072644 Inhibitory chimeric antigen receptors Arvind Rajpal, Shobha Potluri, Laurent POIROT, Alexandre Juillerat, Donna Marie Stone +1 more 2021-07-27
10294304 Chimeric antigen receptors targeting B-cell maturation antigen Tracy Chia-Chien KUO, Bijan Andre Boldajipour, Javier Fernando Chaparro Riggers, Philippe Duchateau, Roman Galetto +6 more 2019-05-21